Sonoma Pharmaceuticals, Inc. (SNOA): Free Cash Flow
-$4.12M
Year ended 2026-03-31
-$2.65M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | -$4.12M | n/m | 2026-06-16, From 2025-04-01 |
| 2025-03-31 | -$168.0K | n/m | 2026-06-16, From 2024-04-01 |
| 2024-03-31 | -$2.40M | n/m | 2025-06-17, From 2023-04-01 |
| 2023-03-31 | -$6.42M | n/m | 2024-06-17, From 2022-04-01 |
| 2022-03-31 | -$4.38M | n/m | 2023-06-21, From 2021-04-01 |
| 2021-03-31 | -$3.56M | n/m | 2022-07-13, From 2020-04-01 |
| 2020-03-31 | -$4.80M | n/m | 2021-07-14, From 2019-04-01 |
| 2019-03-31 | -$11.82M | n/m | 2020-07-10, From 2018-04-01 |
| 2018-03-31 | -$12.63M | n/m | 2019-07-01, From 2017-04-01 |
| 2017-03-31 | -$8.56M | n/m | 2018-06-26, From 2016-04-01 |
| 2016-03-31 | -$9.09M | n/m | 2017-06-28, From 2015-04-01 |
| 2015-03-31 | -$6.83M | n/m | 2016-06-21, From 2014-04-01 |
| 2014-03-31 | -$5.39M | n/m | 2015-06-16, From 2013-04-01 |
| 2013-03-31 | $893.0K | n/m | 2014-06-30, From 2012-04-01 |
| 2012-03-31 | -$4.37M | n/m | 2013-06-25, From 2011-04-01 |
| 2011-03-31 | -$4.60M | n/a | 2012-06-21, From 2010-04-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | -$4.12M | n/m |
| Nephros Inc (NEPH) | 2024-12-31 | -$555.0K | n/a |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | -$17.60M | n/m |
| DarioHealth Corp. (DRIO) | 2025-12-31 | -$26.08M | n/m |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | -$1.39M | n/m |
| Profound Medical Corp. (PROF) | 2025-12-31 | -$38.38M | n/a |
| Allurion Technologies, Inc. (ALUR) | 2024-12-31 | -$42.91M | n/m |
| Sensus Healthcare, Inc. (SRTS) | 2025-12-31 | $332.0K | n/m |
| Premier Air Charter Holdings Inc. (PREM) | 2025-12-31 | -$1.40M | n/m |
Compare SNOA, NEPH, VVOS, DRIO side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗